Diagnosis and Natural History of HIV-Associated Nephropathy

Gardenswartz, 1984, Renal disease in patients with AIDS: A clinicopathologic study, Clin Nephrol, 21, 197 Pardo, 1984, Glomerular lesions in the acquired immunodeficiency syndrome, Ann Intern Med, 101, 429, 10.7326/0003-4819-101-4-429 Rao, 1984, Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome, N Engl J Med, 310, 669, 10.1056/NEJM198403153101101 Mazbar, 1990, Renal involvement in patients infected with HIV: Experience at San Francisco General Hospital, Kidney Int, 37, 1325, 10.1038/ki.1990.118 Ross, 2002, Recent progress in HIV-associated nephropathy, J Am Soc Nephrol, 13, 2997, 10.1097/01.ASN.0000040750.40907.99 Carbone, 1989, Course and prognosis of human immunodeficiency virus-associated nephropathy, Am J Med, 87, 389, 10.1016/S0002-9343(89)80819-8 Cantor, 1991, Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy, Arch Intern Med, 151, 125, 10.1001/archinte.151.1.125 Laradi, 1998, HIV-associated nephropathy: outcome and prognosis factors. Groupe d' Etudes Nephrologiques d'Ile de France, J Am Soc Nephrol, 9, 2327, 10.1681/ASN.V9122327 Williams, 1998, Presentation, pathology, and outcome of HIV associated renal disease in a specialist centre for HIV/AIDS, Sex Transm Infect, 74, 179, 10.1136/sti.74.3.179 Abbott, 2001, Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: Patient characteristics and survival in the pre highly active antiretroviral therapy era, J Nephrol, 14, 377 Kopp, 2003, HIV-associated nephropathy in African Americans, Kidney Int Suppl, 83, S43, 10.1046/j.1523-1755.63.s83.10.x Eggers, 2004, Is there an epidemic of HIV Infection in the US ESRD program?, J Am Soc Nephrol, 15, 2477, 10.1097/01.ASN.0000138546.53152.A7 Shahinian, 2000, Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients, Am J Kidney Dis, 35, 884, 10.1016/S0272-6386(00)70259-9 Nochy, 1993, Renal disease associated with HIV infection: A multicentric study of 60 patients from Paris hospitals, Nephrol Dial Transplant, 8, 11, 10.1093/oxfordjournals.ndt.a092263 Nochy, 1993, Renal lesions associated with human immunodeficiency virus infection: North American vs. European experience, Adv Nephrol Necker Hosp, 22, 269 Lucas, 2007, End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004, AIDS, 21, 2435, 10.1097/QAD.0b013e32827038ad Bruggeman, 2000, Renal epithelium is a previously unrecognized site of HIV-1 infection, J Am Soc Nephrol, 11, 2079, 10.1681/ASN.V11112079 Gharavi, 2004, Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3, Proc Natl Acad Sci U S A, 101, 2488, 10.1073/pnas.0308649100 Papeta, 2009, Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression, J Clin Invest, 119, 1178, 10.1172/JCI37131 Kopp, 2008, MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis, Nat Genet, 40, 1175, 10.1038/ng.226 Winston, 2001, Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection, N Engl J Med, 344, 1979, 10.1056/NEJM200106283442604 Szabo, 2002, Unusual presentations of primary human immunodeficiency virus infection, AIDS Patient Care STDS, 16, 251, 10.1089/10872910260066688 Izzedine, 2005, Viral load and HIV-associated nephropathy, N Engl J Med, 353, 1072, 10.1056/NEJMc051607 Estrella, 2006, HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients, Clin Infect Dis, 43, 377, 10.1086/505497 Zhong, 2005, Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy, Kidney Int, 68, 1048, 10.1111/j.1523-1755.2005.00497.x He, 2004, Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways, J Clin Invest, 114, 643, 10.1172/JCI200421004 Hanna, 1998, Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice, Cell, 95, 163, 10.1016/S0092-8674(00)81748-1 Hanna, 1998, Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease, J Virol, 72, 121, 10.1128/JVI.72.1.121-132.1998 Zuo, 2006, HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis, J Am Soc Nephrol, 17, 2832, 10.1681/ASN.2005080878 Marras, 2002, Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy, Nat Med, 8, 522, 10.1038/nm0502-522 Lu, 2008, HIV-1 nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein, J Biol Chem, 283, 8173, 10.1074/jbc.M708920200 Conaldi, 2002, Human immunodeficiency virus-1 tat induces hyperproliferation and dysregulation of renal glomerular epithelial cells, Am J Pathol, 161, 53, 10.1016/S0002-9440(10)64156-9 Wali, 1998, HIV-1-associated nephropathy and response to highly-active antiretroviral therapy, Lancet, 352, 783, 10.1016/S0140-6736(98)24037-2 Lucas, 2004, Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study, AIDS, 18, 541, 10.1097/00002030-200402200-00022 Atta, 2006, Antiretroviral therapy in the treatment of HIV-associated nephropathy, Nephrol Dial Transplant, 21, 2809, 10.1093/ndt/gfl337 Scialla, 2007, Relapse of HIV-associated nephropathy after discontinuing highly active antiretroviral therapy, AIDS, 21, 263, 10.1097/QAD.0b013e3280119592 Winston, 1999, HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection, Kidney Int, 55, 1036, 10.1046/j.1523-1755.1999.0550031036.x Levin, 2001, HIV-associated nephropathy occurring before HIV antibody seroconversion, Am J Kidney Dis, 37, E39, 10.1016/S0272-6386(05)90003-6 Ross, 2000, HIV-associated nephropathy: Case study and review of the literature, AIDS Patient Care STDS, 14, 637, 10.1089/10872910050206559 Berliner, 2008, Observations on a cohort of HIV-infected patients undergoing native renal biopsy, Am J Nephrol, 28, 478, 10.1159/000112851 Han, 2006, A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa, Kidney Int, 69, 2243, 10.1038/sj.ki.5000339 D'Agati, 1989, Pathology of HIV-associated nephropathy: A detailed morphologic and comparative study, Kidney Int, 35, 1358, 10.1038/ki.1989.135 D'Agati, 1997, HIV infection and the kidney, J Am Soc Nephrol, 8, 138, 10.1681/ASN.V81138 Albaqumi, 2006, Collapsing glomerulopathy, J Am Soc Nephrol, 17, 2854, 10.1681/ASN.2006030225 Post, 2008, Predictors of renal outcome in HIV-associated nephropathy, Clin Infect Dis, 46, 1282, 10.1086/529385 Atta, 2004, Sonography as a predictor of human immunodeficiency virus-associated nephropathy, J Ultrasound Med, 23, 603, 10.7863/jum.2004.23.5.603 Atta, 2005, Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathy, Am J Med, 118, 1288.e1221, 10.1016/j.amjmed.2005.05.027 Eustace, 2000, Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids, Kidney Int, 58, 1253, 10.1046/j.1523-1755.2000.00280.x Burns, 1997, Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy, J Am Soc Nephrol, 8, 1140, 10.1681/ASN.V871140 Smith, 1996, Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy, Am J Med, 101, 41, 10.1016/S0002-9343(96)00065-4 Briggs, 1996, Clinicopathologic correlates of prednisone treatment of human immunodeficiency virus-associated nephropathy, Am J Kidney Dis, 28, 618, 10.1016/S0272-6386(96)90477-1 Burns, 1994, Response to inhibition of angiotensin-converting enzyme in human immunodeficiency virus-associated nephropathy: A case report, Am J Kidney Dis, 23, 441, 10.1016/S0272-6386(12)81009-2 Hammer, 2008, Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel, JAMA, 300, 555, 10.1001/jama.300.5.555 He, 2007, Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway, J Am Soc Nephrol, 18, 93, 10.1681/ASN.2006070727 Available at: http://www.hivtransplant.com/. Accessed May 28, 2009 Rao, 1987, The types of renal disease in the acquired immunodeficiency syndrome, N Engl J Med, 316, 1062, 10.1056/NEJM198704233161705 Szczech, 2004, The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection, Kidney Int, 66, 1145, 10.1111/j.1523-1755.2004.00865.x Ortiz, 1988, Outcome of patients with human immunodeficiency virus on maintenance hemodialysis, Kidney Int, 34, 248, 10.1038/ki.1988.172 Tebben, 1993, Outcome of HIV infected patients on continuous ambulatory peritoneal dialysis, Kidney Int, 44, 191, 10.1038/ki.1993.230 Ahuja, 2002, Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States, J Am Soc Nephrol, 13, 1889, 10.1097/01.ASN.0000019773.43765.BF Macrae, 2005, Improved survival in HIV-infected African-Americans with ESRD, Clin Nephrol, 64, 124, 10.5414/CNP64124 Atta, 2007, Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland, Clin Infect Dis, 45, 1625, 10.1086/523728 US Renal Data System (USRDS): 2006 Annual Data Report: National Institutes of Health, National Institute of Diabetes and Digestive Diseases and Kidney Diseases, Bethesda, MD. http://www.usrds.org Accessed January 8, 2008 Ahuja, 1999, Is the prevalence of HIV-associated nephropathy decreasing?, Am J Nephrol, 19, 655, 10.1159/000013537